Klinikum Ernst von Bergmann gemeinnützige GmbH
Potsdam, Germany
Cancer treatment center in Potsdam, Brandenburg
Charlottenstraße 72, 14467 Potsdam
About Klinikum Ernst von Bergmann gemeinnützige GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Helsinn Healthcare SA
1
Laminate Medical Technologies
1
Clinical Trials at Klinikum Ernst von Bergmann gemeinnützige GmbH
During the past decade, Klinikum Ernst von Bergmann gemeinnützige GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
2017-09-07
2021-01-11
Completed
80
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
2021-02-01
2024-11-30
Recruiting
530
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Ernst von Bergmann gemeinnützige GmbH
According to Clinical.Site data, the most researched conditions in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are
"Arterio-Venous Fistula" (1 trials), "Arteriovenous Fistula Thrombosis" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials), "ESRD" (1 trials) and "Kidney Diseases" (1 trials). Many other conditions were trialed in "Klinikum Ernst von Bergmann gemeinnützige GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Ernst von Bergmann gemeinnützige GmbH
Most popular intervention types in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone, 8 mg (oral) or equivalent IV dose" (1 trials), "Granisetron, 2 mg (oral) or 1 mg (IV) OR Palonosetron, 0.5 mg (oral), 0.25mg (IV) OR Ondansetron, 16 mg (oral) or 8 mg (IV) OR Dolasetron 100 mg (oral) OR Tropisetron 5 mg (oral or IV)" (1 trials), "NEPA (300mg netupitant/0.5mg palonosetron)" (1 trials) and "VasQ" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Ernst von Bergmann gemeinnützige GmbH
The vast majority of trials in "Klinikum Ernst von Bergmann gemeinnützige GmbH" are
2 trials for "All" genders.
Clinical Trials Status at Klinikum Ernst von Bergmann gemeinnützige GmbH
Currently, there are NaN active trials in "Klinikum Ernst von Bergmann gemeinnützige GmbH".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Ernst von Bergmann gemeinnützige GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Ernst von Bergmann gemeinnützige GmbH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".